Odeberg, Jacob
Halling, Anders
Ringborn, Michael
Freitag, Michael
Persson, Marie Louise
Vaara, Ivar
Råstam, Lennart
Odeberg, Håkan
Lindblad, Ulf
Funding for this research was provided by:
Stockholm Regional Council (FoUI-949280)
VINNOVA (2011-02497, 2011-02497)
The Royal Institute of Technology (Faculty Grant)
HelseNord (HNF1544-20)
Landstinget Blekinge
Ingemanssonska Foundation
The Operational Healthcare Committee, Region Västra Götaland
Royal Institute of Technology
Article History
Received: 25 August 2024
Accepted: 25 February 2025
First Online: 15 March 2025
Declarations
:
: Carlscrona Heart Attack Prognosis Study (CHAPS) was approved by the Regional Ethical Review Board, Lund, Sweden (EPN 2009/762 and LU 298–91). All participants gave their informed consent before taking part.
: N/A.
: The authors declare no competing interests.